Boots Owner Nears $9bn Sale to Canada's Weston Family

Sycamore Partners, the private equity owner of the high street pharmacy chain Boots, is reportedly nearing a sale agreement with the Canadian branch of the billionaire Weston family. The proposed deal values Boots at $9 billion (£7 billion). The Financial Times has reported that advanced negotiations are underway, with a potential completion as early as next week. This potential acquisition marks a significant return for the Weston family to the UK retail landscape, following their sale of the Selfridges department store for £4 billion in 2022. Sycamore Partners had previously acquired the broader Walgreens Boots Alliance for $23.7 billion in 2025, indicating a substantial divestment strategy for the Boots business. The Weston family, a prominent Canadian business dynasty, has a long history in retail and has previously owned a significant stake in Associated British Foods, which operates brands like Primark. Their potential re-entry into the UK market through Boots signifies a strategic move into the pharmacy and health and beauty sectors. The sale process, if finalized, would represent one of the largest retail transactions in the UK in recent years. Boots, a household name in the UK, operates over 2,200 stores across the country, offering a wide range of pharmaceutical products, health services, and beauty items. The company has been a staple on British high streets for decades, and its ownership has been a subject of considerable interest since its separation from Walgreens. The valuation of $9 billion suggests a strong belief in the future profitability and market position of Boots, even amidst evolving retail dynamics and increased competition. The Financial Times' reporting, citing sources familiar with the matter, adds significant weight to the ongoing discussions. The potential involvement of the Weston family, known for their long-term investment approach and successful retail ventures, could signal a period of renewed investment and strategic development for Boots. This transaction underscores the ongoing consolidation and strategic realignments within the global retail and private equity sectors. The specific terms of the deal, including any conditions or regulatory approvals required, are yet to be disclosed. However, the reported progress in talks indicates a high degree of confidence from both Sycamore Partners and the Weston family regarding the viability of the acquisition. The outcome of these negotiations will be closely watched by investors, competitors, and consumers alike, as it could shape the future of a significant player in the UK's retail and healthcare market.